Effects of chronic low dose rotenone treatment on human microglial cells

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Shaikh, Shamim B ^a   Nicholson, Louise F B ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HERBICIDE; REACTIVE OXYGEN METABOLITE; ROTENONE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LONG TERM EXPOSURE; LOW DRUG DOSE; MICROGLIA; NERVE CELL; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE;

ANIMALIA;

EID: 74849095736     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-55     Document Type: Article

References (66)

1. The journey: Parkinson's disease. MG Baker L Graham, BMJ 2004 329 611 614 10.1136/bmj.329.7466.611 15361447
2. A highly reproducible rotenone model of Parkinson's disease. JR Cannon V Tapias HM Na AS Honick RE Drolet JT Greenamyre, Neurobiol Dis 2009 34 279 290 10.1016/j.nbd.2009.01.016 19385059
3. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. HM Gao PT Kotzbauer K Uryu S Leight JQ Trojanowski VM Lee, J Neurosci 2008 28 7687 7698 10.1523/JNEUROSCI.0143-07.2008 18650345
4. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? EC Hirsch S Hunot P Damier B Faucheux, Ann Neurol 1998 44 115 120 9749582
5. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. PL McGeer S Itagaki BE Boyes EG McGeer, Neurology 1988 38 1285 1291 3399080
6. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. LJ Lawson VH Perry P Dri S Gordon, Neuroscience 1990 39 151 170 10.1016/0306-4522(90)90229-W 2089275
7. The role of environmental agents in Parkinson's disease. DA Di Monte, Clinical Neuroscience Research 2001 1 419 426 10.1016/S1566-2772(01)00020-2 (Pubitemid 33665560)
8. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. DM Gash K Rutland NL Hudson PG Sullivan G Bing WA Cass JD Pandya M Liu DY Choi RL Hunter GA Gerhardt CD Smith JT Slevin TS Prince, Ann Neurol 2008 63 184 192 10.1002/ana.21288 18157908
9. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. JM Gorell CC Johnson BA Rybicki EL Peterson RJ Richardson, Neurology 1998 50 1346 1350 9595985
10. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. HH Liou MC Tsai CJ Chen JS Jeng YC Chang SY Chen RC Chen, Neurology 1997 48 1583 1588 9191770
11. Parkinson's disease mortality and pesticide exposure in California 1984-1994. B Ritz F Yu, International journal of epidemiology 2000 29 323 329 10.1093/ije/29.2.323 10817132
12. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. R Betarbet TB Sherer G MacKenzie M Garcia-Osuna AV Panov JT Greenamyre, Nat Neurosci 2000 3 1301 1306 10.1038/81834 11100151
13. Toxin-induced models of Parkinson's disease. J Bove D Prou C Perier S Przedborski, NeuroRx 2005 2 484 494 10.1602/neurorx.2.3.484 16389312
14. Animal models of Parkinson's disease. R Betarbet TB Sherer JT Greenamyre, Bioessays 2002 24 308 318 10.1002/bies.10067 11948617
15. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. TB Sherer R Betarbet AK Stout S Lund M Baptista AV Panov MR Cookson JT Greenamyre, J Neurosci 2002 22 7006 7015 12177198
16. Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and [alpha]-Synuclein Aggregation. TB Sherer J-H Kim R Betarbet JT Greenamyre, Experimental Neurology 2003 179 9 16 10.1006/exnr.2002.8072 12504863
17. Rotenone induces non-specific central nervous system and systemic toxicity. N Lapointe M St-Hilaire MG Martinoli J Blanchet P Gould C Rouillard F Cicchetti, Faseb J 2004 18 717 719 14766796
18. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. GU Hoglinger J Feger A Prigent PP Michel K Parain P Champy M Ruberg WH Oertel EC Hirsch, J Neurochem 2003 84 491 502 10.1046/j.1471-4159. 2003.01533.x 12558969
19. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease. TB Sherer R Betarbet CM Testa BB Seo JR Richardson JH Kim GW Miller T Yagi A Matsuno-Yagi JT Greenamyre, J Neurosci 2003 23 10756 10764 14645467 (Pubitemid 37499681)
20. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. K Radad WD Rausch G Gille, Neurochem Int 2006 49 379 386 10.1016/j.neuint.2006.02.003 16580092
21. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. S Shaikh LF Nicholson, J Neurosci Res 2008 86 2071 2082 10.1002/jnr.21644 18335520
22. Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons. H-M Gao J-S Hong W Zhang B Liu, J Neurosci 2002 22 782 790 11826108
23. Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons. H-M Gao B Liu J-S Hong, J Neurosci 2003 23 6181 6187 12867501
24. Species differences in the generation of reactive oxygen species by microglia. C Colton S Wilt D Gilbert O Chernyshev J Snell M Dubois-Dalcq, Molecular and Chemical Neuropathology 1996 28 15 20 10.1007/BF02815200 8871937
25. The adult human brain in preclinical drug development. M Dragunow, Nat Rev Drug Discov 2008 7 659 666 10.1038/nrd2617 18617887
26. Increased MCP-1 and microglia in various regions of the human alcoholic brain. J He FT Crews, Experimental neurology 2008 210 349 358 10.1016/j.expneurol.2007.11.017 18190912
27. Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections. Y Horikoshi A Sasaki N Taguchi M Maeda H Tsukagoshi K Sato H Yamaguchi, Acta Neuropathologica 2003 105 157 162 12536226
28. Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. A Panov S Dikalov N Shalbuyeva G Taylor T Sherer JT Greenamyre, J Biol Chem 2005 280 42026 42035 10.1074/jbc.M508628200 16243845
29. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. BI Giasson JE Duda IV Murray Q Chen JM Souza HI Hurtig H Ischiropoulos JQ Trojanowski VM Lee, Science 2000 290 985 989 10.1126/science.290.5493.985 11062131
30. {alpha}-Synuclein Expression Modulates Microglial Activation Phenotype. SA Austin AM Floden EJ Murphy CK Combs, J Neurosci 2006 26 10558 10563 10.1523/JNEUROSCI.1799-06.2006 17035541
31. Postischemic alterations of BDNF, NGF, HSP 70 and ubiquitin immunoreactivity in the gerbil hippocampus: pharmacological approach. T Himeda H Tounai N Hayakawa T Araki, Cellular and molecular neurobiology 2007 27 229 250 10.1007/s10571-006-9104-2 16810563
32. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. CM Testa TB Sherer JT Greenamyre, Brain Res Mol Brain Res 2005 134 109 118 10.1016/j.molbrainres.2004.11.007 15790535
33. Oxidative and antioxidative potential of brain microglial cells. R Dringen, Antioxid Redox Signal 2005 7 1223 1233 10.1089/ars.2005.7.1223 16115027
34. Superoxide anion radical (O2-.), superoxide dismutases, and related matters. I Fridovich, J Biol Chem 1997 272 18515 18517 10.1074/jbc.272.30.18515 9228011
35. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. C Cheret A Gervais A Lelli C Colin L Amar P Ravassard J Mallet A Cumano KH Krause M Mallat, J Neurosci 2008 28 12039 12051 10.1523/JNEUROSCI.3568-08. 2008 19005069
36. Measurement and Characterization of Superoxide Generation in Microglial Cells: Evidence for an NADPH Oxidase-Dependent Pathway. S Sankarapandi JL Zweier G Mukherjee MT Quinn DL Huso, Archives of Biochemistry and Biophysics 1998 353 312 321 10.1006/abbi.1998.0658 9606965
37. Biological Roles for the NOX Family NADPH Oxidases. WM Nauseef, J Biol Chem 2008 283 16961 16965 10.1074/jbc.R700045200 18420576
38. Peroxynitrite mediated damage and lowered superoxide tolerance in primary cortical glial cultures after induction of the inducible isoform of NOS. H Noack H Possel C Rethfeldt G Keilhoff G Wolf, Glia 1999 28 13 24 10.1002/(SICI)1098-1136(199910)28:1<13:AID-GLIA2>3.0.CO;2-L 10498818
39. Activation of NADPH oxidase in Alzheimer's disease brains. S Shimohama H Tanino N Kawakami N Okamura H Kodama T Yamaguchi T Hayakawa A Nunomura S Chiba G Perry MA Smith S Fujimoto, Biochem Biophys Res Commun 2000 273 5 9 10.1006/bbrc.2000.2897 10873554
40. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease. DC Wu P Teismann K Tieu M Vila V Jackson-Lewis H Ischiropoulos S Przedborski, Proc Natl Acad Sci USA 2003 100 6145 6150 10.1073/pnas.0937239100 12721370
41. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? D Zekry TK Epperson KH Krause, IUBMB life 2003 55 307 313 10.1080/1521654031000153049 12938732
42. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. B Halliwell, Drugs & aging 2001 18 685 716
43. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. B Liu L Du JS Hong, J Pharmacol Exp Ther 2000 293 607 617 10773035
44. Oxidative mechanisms in nigral cell death in Parkinson's disease. P Jenner, Mov Disord 1998 13 Suppl 1 24 34 9613715
45. Mitochondrial dysfunction in Parkinson's disease. JT Greenamyre G MacKenzie TI Peng SE Stephans, Biochem Soc Symp 1999 66 85 97 10989660
46. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. H Jiang N Song J Wang LY Ren JX Xie, Neurochem Int 2007 51 32 36 10.1016/j.neuint.2007.03.006 17490790
47. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. E Hasegawa K Takeshige T Oishi Y Murai S Minakami, Biochem Biophys Res Commun 1990 170 1049 1055 10.1016/0006-291X(90)90498-C 2167668
48. Ascorbate regulation and its neuroprotective role in the brain. ME Rice, Trends in neurosciences 2000 23 209 216 10.1016/S0166-2236(99)01543-X 10782126
49. Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type-specific distribution. S Chatterjee H Noack H Possel G Keilhoff G Wolf, Glia 1999 27 152 161 10.1002/(SICI)1098-1136(199908)27: 2<152:AID-GLIA57>3.0.CO;2-Q 10417814
50. Glial cell type-specific responses to menadione-induced oxidative stress. SB Hollensworth C Shen JE Sim DR Spitz GL Wilson SP LeDoux, Free radical biology & medicine 2000 28 1161 1174
51. Induction of nitric oxide synthesis in J774 cells lowers intracellular glutathione: effect of modulated glutathione redox status on nitric oxide synthase induction. JS Hothersall FQ Cunha GH Neild AA Norohna-Dutra, Biochem J 1997 322 Pt 2 477 481 9065766
52. Cellular distribution of superoxide dismutases in the rat CNS. J Lindenau H Noack H Possel K Asayama G Wolf, Glia 2000 29 25 34 10.1002/(SICI)1098- 1136(20000101)29:1<25:AID-GLIA3>3.0.CO;2-G 10594920
53. Co-induction of heme oxygenase-1 and peroxiredoxin I in astrocytes and microglia around hemorrhagic region in the rat brain. K Nakaso M Kitayama E Mizuta H Fukuda T Ishii K Nakashima K Yamada, Neuroscience letters 2000 293 49 52 10.1016/S0304-3940(00)01491-9 11065135
54. Hydrogen peroxide enhances phagocytic activity of ameboid microglia. H Takeda M Tomita N Tanahashi M Kobari M Yokoyama M Takao D Ito Y Fukuuchi, Neuroscience letters 1998 240 5 8 10.1016/S0304-3940(97)00917-8 9488161
55. Effect of ammonia on endocytosis and cytokine production by immortalized human microglia and astroglia cells. CL Atanassov CD Muller S Dumont G Rebel P Poindron N Seiler, Neurochem Int 1995 27 417 424 10.1016/0197-0186(95)00023-2 8845742
56. Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. S Peudenier C Hery L Montagnier M Tardieu, Annals of neurology 1991 29 152 161 10.1002/ana.410290207 1707249
57. Metabolic and cellular characterization of immortalized humanmicroglial cells under heat stress. FM-P de Gannes M Merle P Canioni P-J Voisin, Neurochemistry International 1998 33 61 73 10.1016/S0197-0186(05)80010-5 9694044
58. Mitochondrial impairment and recovery after heat shock treatment in a human microglial cell line. F Macouillard-Poulletier de Gannes N Leducq P Diolez F Belloc M Merle P Canioni P-J Voisin, Neurochemistry International 2000 36 233 241 10.1016/S0197-0186(99)00118-7 10676858
59. Differential autocrine modulation of atrial and ventricular potassium currents and of oxidative stress in diabetic rats. Y Shimoni D Hunt K Chen T Emmett G Kargacin, Am J Physiol Heart Circ Physiol 2006 290 1879 1888 10.1152/ajpheart.01045.2005 16339825
60. Chemiluminescence as diagnostic tool. A review. C Dodeigne L Thunus R Lejeune, Talanta 2000 51 415 439 10.1016/S0039-9140(99)00294-5 18967873
61. Chemiluminescent Real Time Imaging of Post-Ischemic Oxygen Free Radicals Formation in Livers Isolated From Young and Old Rats. A Gasbarrini P Pasini B Nardo S De Notariis M Simoncini A Cavallari E Roda M Bernardi A Roda, Free Radical Biology and Medicine 1998 24 211 216 10.1016/S0891-5849(97)00056-7 9433894
62. Evaluation of antioxidants using oxidation reaction rate constants. Y Shi X Zhan L Ma L Li C Li, Frontiers of Chemistry in China 2007 2 140 145 10.1007/s11458-007-0029-1
63. Serial killers: ordering caspase activation events in apoptosis. EA Slee C Adrain SJ Martin, Cell death and differentiation 1999 6 1067 1074 10.1038/sj.cdd.4400601 10578175
64. Expression of glucose transporter 5 by microglia in human gliomas. A Sasaki H Yamaguchi Y Horikoshi G Tanaka Y Nakazato, Neuropathology and applied neurobiology 2004 30 447 455 10.1111/j.1365-2990.2004.00556.x 15488021
65. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. MB Graeber K Bise P Mehraein, Neuropathology and applied neurobiology 1994 20 406 408 10.1111/j.1365-2990.1994.tb00987.x 7808591
66. Microglial activation in early stages of amyloid protein deposition. A Sasaki H Yamaguchi A Ogawa S Sugihara Y Nakazato, Acta Neuropathologica 1997 94 316 322 10.1007/s004010050713 9341931